Clinical Trial Update: Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating antiviral activity of a small-molecule direct-acting antiviral agent across multiple doses in subjects with chronic hepatitis C. Result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Pfizer | Conditions: Hepatitis, Chronic, Hepatitis C Virus | Phase 1 | Status: COMPLETED | Results posted: 2014-01-14